The foundation soon changed its name to Hope Happens to emphasis its focus on all neurological disorders.
In November of 2004, Hope Happens partnered with Washington University to launch the Hope Center for Neurological Disorders at Washington University in St. Louis, a research center dedicated to speeding the process of translating basic scientific discoveries into therapies and cures. Both partners are convinced that discoveries in one disorder will lead to progress with others.
Board of Directors
- Hannah Sayers, President
(Marketing Director, Lewis Rice)
- Josh Reinert, Vice-President
(Principal, Carmody MacDonald P.C.)
- Lincoln Gray, (Partner, Brown Smith Wallace)
- T. William Hizar, Principal, Edward Jones
- Christopher Imming, Treasurer
(Regional President, Midwest BankCentre)
- Hilary Murphy
- Leigh Hobler Gerard
(Counselor, St. Louis Psychoanalytic Institute)
- Cary Schneithorst Reed
(Community philanthropic supporter, Board Member at COCA, Owner Schneithorst’s Interiors)
- Glen Stettin, M.D.
(SVP, Clinical, Research & New Solutions, Express Scripts/Cigna)
- Colby Schmid, (Senior VP of Commercial Banking Citizens National Bank)
- Abigail Miller (Gladitood)
- Jennifer Everly (President, Everly Accounting)
- Julie Lynch, Communications Officer (Myovant Sciences)
- Patrick Cullity (Stryker)
- Mark Menghini (General Council, Aegion)
Hope Happens News
Your contributions to Hope Happens have a lasting impact, and great news keeps coming from the Hope Center for Neurological Disorders. This year, researchers at the Hope Center for Neurological Disorders lead by Dr. Randell Bateman developed a blood test for...
Great news from the Hope Center - Tim Miller, MD, PhD, who is one of the nation’s foremost researchers on ALS, developed an experimental drug (tofersen) for a form of genetic ALS that is now moving into a Phase 3 clinical trial. Phase 3 is designed to further evaluate...